3

OWNERSHIP DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: July 19, 2019
Period of Report: July 18, 2019
Accession Number: 0001144204-19-035233

View Document ↗ View on SEC.gov ↗